Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-11-26

FDA Approved: MIRTAZAPINE — Supplemental Application (Aurolife Pharma LLC)

View source ↗

Summary

FDA granted a supplemental approval to Aurolife Pharma LLC for Mirtazapine (generic antidepressant) under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • mirtazapine (mirtazapine)

Snippet

SUPPL AP for MIRTAZAPINE (MIRTAZAPINE)